PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Partial cardiac denervation to prevent postoperative atrial fibrillation after coronary artery bypass grafting

JAMA Cardiology

2024-11-17
(Press-News.org)

About The Study: This randomized clinical trial found that partial cardiac denervation was an effective procedure to reduce the occurrence of postoperative atrial fibrillation (POAF) after isolated coronary artery bypass grafting (CABG) without additional postoperative complications. These results suggest that partial cardiac denervation may be a good option for cardiac surgeons to consider for preventing POAF after CABG.

Corresponding Authors: To contact the corresponding authors, email Wei Feng, MD, PhD (fengwei@fuwai.com) and Wei Zhao, MD, PhD (zhaowei_fw@163.com).

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamacardio.2024.4639)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2024.4639?guestAccessKey=508520f8-6b48-4a01-9cc3-7903d9033804&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111724

 

END



ELSE PRESS RELEASES FROM THIS DATE:

Finerenone in women and men with heart failure with mildly reduced or preserved ejection fraction

2024-11-17
About The Study: In the Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in Patients with Heart Failure (FINEARTS-HF), finerenone reduced the risk of the primary end point similarly in women and men with heart failure with mildly reduced or preserved ejection fraction. Finerenone, a nonsteroidal mineralocorticoid receptor antagonist, had similar tolerability in women and men. Corresponding Author: To contact the corresponding author, John J. V. McMurray, MD, email john.mcmurray@glasgow.ac.uk. To ...

Finerenone, serum potassium, and clinical outcomes in heart failure with mildly reduced or preserved ejection fraction

2024-11-17
About The Study: In patients with heart failure with mildly reduced or preserved ejection fraction, finerenone, a nonsteroidal mineralocorticoid receptor antagonist, resulted in more frequent hyperkalemia and less frequent hypokalemia. However, with protocol-directed surveillance and dose adjustment, clinical benefit associated with finerenone relative to placebo was maintained even in those whose potassium level increased to greater than 5.5 mmol/L. Corresponding Author: To contact the corresponding author, Scott D. Solomon, MD, email ssolomon@rics.bwh.harvard.edu.  To access the embargoed study: Visit our ...

Hormone therapy reshapes the skeleton in transgender individuals who previously blocked puberty

2024-11-17
Skeletal size may be altered by gender-affirming hormone therapy only if puberty has also been suppressed during adolescence, according to research presented at the 62nd Annual European Society for Paediatric Endocrinology Meeting in Liverpool. The findings from this research, carried out by Amsterdam UMC, not only help researchers further understand the roles sex hormones play on the skeleton but may also improve counselling on gender-affirming treatment in transgender individuals. Skeletons of men and women vary in size and proportion. For instance, men typically have broader shoulders while women have a wider pelvis. Gender-affirming hormones ...

Evaluating performance and agreement of coronary heart disease polygenic risk scores

2024-11-16
About The Study: Coronary heart disease polygenic risk scores that performed similarly at the population level demonstrated highly variable individual-level estimates of risk. Recognizing that coronary heart disease polygenic risk scores may generate incongruent individual-level risk estimates, effective clinical implementation will require refined statistical methods to quantify uncertainty and new strategies to communicate this uncertainty to patients and clinicians.  Corresponding Author: To contact the corresponding author, Scott M. Damrauer, MD, email Scott.Damrauer@pennmedicine.upenn.edu. To access the embargoed study: Visit our For The Media website at this link ...

Heart failure in zero gravity— external constraint and cardiac hemodynamics

2024-11-16
About The Study: In this case series study, pulmonary artery systolic, diastolic, and mean pressures of 2 participants with obesity and heart failure with preserved ejection fraction were measured at zero gravity during parabolic flight to assess the effect of external constraint on left ventricular filling pressures.  Corresponding Author: To contact the corresponding author, Benjamin D. Levine, MD, email benjaminlevine@texashealth.org. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/   (doi:10.1001/jamacardio.2024.4596) Editor’s Note: Please see the article for additional information, including ...

Amid record year for dengue infections, new study finds climate change responsible for 19% of today’s rising dengue burden

2024-11-16
NEW ORLEANS (November 16, 2024) — Climate change is having a massive global impact on dengue transmission, accounting for 19% of the current dengue burden, with a potential to spark an additional 40%-60% spike by 2050 — and by as much as 150%-200% in some areas — according to a new study presented today at the Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH). The findings from researchers at Stanford and Harvard Universities offer the most definitive evidence to date that climate change is ...

New study finds air pollution increases inflammation primarily in patients with heart disease

New study finds air pollution increases inflammation primarily in patients with heart disease
2024-11-16
A new study by heart researchers at Intermountain Health in Salt Lake City finds that patients with heart disease, specifically those with heart failure, are especially vulnerable to the impacts of air pollution and poor air quality and can take steps to protect themselves.  Results from the Intermountain Health study, presented on Saturday at the American Heart Association’s 2024 Scientific Sessions international conference in Chicago, found that two inflammatory markers — CCL27 (C-C motif chemokine ligand 27) ...

AI finds undiagnosed liver disease in early stages

2024-11-16
SAN DIEGO, California (Nov. 16, 2024) — Liver disease, which is treatable when discovered early, often goes undetected until late stages, but a new study revealed that an algorithm fueled by artificial intelligence can accurately detect early-stage metabolic-associated steatotic liver disease (MASLD) by using electronic health records. The study was scheduled for presentation today at The Liver Meeting, hosted by the American Association for the Study of Liver Diseases. “A significant proportion of patients who meet criteria for MASLD go undiagnosed,” said Ariana Stuart MD, a resident at University of Washington Internal Medicine ...

The American Society of Tropical Medicine and Hygiene and the Bill & Melinda Gates Foundation announce new research fellowship in malaria genomics in honor of professor Dominic Kwiatkowski

2024-11-16
The American Society of Tropical Medicine and Hygiene and the Bill & Melinda Gates Foundation Announce New Research Fellowship in Malaria Genomics in Honor of Professor Dominic Kwiatkowski New Orleans, Louisiana, November 15, 2024  — The American Society of Tropical Medicine and Hygiene (ASTMH) is proud to announce the establishment of the annual Kwiatkowski Fellowship, a new research initiative in partnership with the Bill & Melinda Gates Foundation (BMGF). This fellowship honors the life and scientific contributions of the late Professor Dominic Kwiatkowski, a pioneer in the field of malaria genomics. The ...

Excessive screen time linked to early puberty and accelerated bone growth

2024-11-16
Exposure to blue light, like that from smartphones or tablets, may accelerate bone growth and bone age, leading to early puberty in rats. This research, presented at the 62nd Annual European Society for Paediatric Endocrinology Meeting in Liverpool, sheds light on how the use of blue light-emitting devices could impact growth and development and raises important questions about the long-term health effects in children, who are increasingly exposed to screens from a young age. As children grow and develop, long bones such ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] Partial cardiac denervation to prevent postoperative atrial fibrillation after coronary artery bypass grafting
JAMA Cardiology